Genmab ADR (NASDAQ: GMAB) is -15.00% lower on its value in year-to-date trading and has touched a low of $17.24 and a high of $28.56 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GMAB stock was last observed hovering at around $22.87 in the last trading session, with the day’s gains setting it 0.76%.
Currently trading at $23.63, the stock is 10.33% and 10.84% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.54 million and changing 3.32% at the moment leaves the stock 11.66% off its SMA200. GMAB registered 13.22% gain for a year compared to 6-month loss of 12.68%. The firm has a 50-day simple moving average (SMA 50) of $21.3192 and a 200-day simple moving average (SMA200) of $21.163376.
The stock witnessed a 13.93% gain in the last 1 month and extending the period to 3 months gives it a 17.39%, and is 7.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.60% over the week and 1.70% over the month.
Genmab ADR (GMAB) has around 2682 employees, a market worth around $14.53B and $3.23B in sales. Current P/E ratio is 13.40 and Fwd P/E is 12.90. Profit margin for the company is 35.11%. Distance from 52-week low is 37.10% and -17.26% from its 52-week high. The company has generated returns on investments over the last 12 months (20.91%).
The EPS is expected to shrink by -8.33% this year
289.0 institutions hold shares in Genmab ADR (GMAB), with institutional investors hold 10.28% of the company’s shares. The shares outstanding are 635.50M, and float is at 615.07M with Short Float at 0.28%. Institutions hold 10.28% of the Float.
The top institutional shareholder in the company is ALLIANCEBERNSTEIN L.P. with over 15.24 million shares valued at $382.93 million. The investor’s holdings represent 23.4845 of the GMAB Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.08 million shares valued at $127.67 million to account for 7.8301 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.23 million shares representing 6.5161 and valued at over $108.15 million, while HARDING LOEVNER LP holds 4.2657 of the shares totaling 2.77 million with a market value of $69.61 million.
